UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of BMI on the survival outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis

BMC cancer, 2023-10, Vol.23 (1), p.1-1023, Article 1023

2023

Volltextzugriff (PDF)

Estimating Boundary Layer Height from LiDAR Data under Complex Atmospheric Conditions Using Machine Learning

Remote sensing (Basel, Switzerland), 2022-01, Vol.14 (2), p.418

2022

Volltextzugriff (PDF)

Efficient Lidar Signal Denoising Algorithm Using Variational Mode Decomposition Combined with a Whale Optimization Algorithm

Remote sensing (Basel, Switzerland), 2019-01, Vol.11 (2), p.126

2019

Volltextzugriff (PDF)

Comparative study on left-sided versus right-sided hepatectomy for resectable peri-hilar cholangiocarcinoma: a systematic review and meta-analysis

World journal of surgical oncology, 2023-05, Vol.21 (1), p.153-153, Article 153

2023

Volltextzugriff (PDF)

Prognostic Value of Peripheral Whole Blood Cell Counts Derived Indexes in Gallbladder Carcinoma: A Systematic Review and Meta-Analysis

Frontiers in oncology, 2021-06, Vol.11, p.707742-707742

2021

Volltextzugriff (PDF)

Real World Experience of Crizotinib in 104 Patients With ALK Rearrangement Non-small-cell Lung Cancer in a Single Chinese Cancer Center

Frontiers in oncology, 2019-10, Vol.9, p.1116-1116

2019

Volltextzugriff (PDF)

Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy

Cancer communications (London, England), 2022-12, Vol.42 (12), p.1331-1346

2022

Volltextzugriff (PDF)

Current management of chemotherapy-induced neutropenia in adults: key points and new challenges

Cancer biology & medicine, 2020-11, Vol.17 (4), p.896-909

2020

Volltextzugriff (PDF)

Sarcopenia Was a Poor Prognostic Predictor for Patients With Advanced Lung Cancer Treated With Immune Checkpoint Inhibitors

Frontiers in nutrition (Lausanne), 2022-07, Vol.9, p.900823-900823

2022

Volltextzugriff (PDF)

An open label, safety study of Asian patients with advanced non-small-cell lung cancer receiving second-line nivolumab monotherapy (CheckMate 870)

Therapeutic advances in medical oncology, 2022-01, Vol.14, p.175883592211383-17588359221138380

2022

Volltextzugriff (PDF)

A phase I study of KH901, a conditionally replicating granulocyte-macrophage colony-stimulating factor: Armed oncolytic adenovirus for the treatment of head and neck cancers

Cancer biology & therapy, 2009-04, Vol.8 (8), p.676-682

2009

Volltextzugriff (PDF)

Rapid and sensitive determination of vinorelbine in human plasma by liquid chromatography–tandem mass spectrometry and its pharmacokinetic application

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011-03, Vol.879 (9), p.662-668

2011

Volltextzugriff (PDF)

A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus

Cancer chemotherapy and pharmacology, 2013-04, Vol.71 (4), p.905-911

2013

Volltextzugriff (PDF)

Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study

Cancer medicine (Malden, MA), 2020-07, Vol.9 (14), p.5134-5142

2020

Volltextzugriff (PDF)

Weekly albumin-bound paclitaxel/cisplatin versus gemcitabine/cisplatin as first-line therapy for patients with advanced non-small-cell lung cancer: A phase II open-label clinical study

Chinese journal of cancer research, 2019-04, Vol.31 (2), p.339-348

2019

Volltextzugriff (PDF)

The P38α rs3804451 Variant Predicts Chemotherapy Response and Survival of Patients with Non–Small Cell Lung Cancer Treated with Platinum-Based Chemotherapy

Translational oncology, 2016-12, Vol.9 (6), p.531-539

2016

Volltextzugriff (PDF)

Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial

The lancet oncology, 2022-02, Vol.23 (2), p.220-233

2022

Volltextzugriff (PDF)

Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trial

Nature medicine, 2022-08, Vol.28 (8), p.1640-1645

2022

Volltextzugriff (PDF)

Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial

Journal of thoracic oncology, 2019-05, Vol.14 (5), p.867-875

2019

Volltextzugriff (PDF)

BCRP gene polymorphisms are associated with susceptibility and survival of diffuse large B-cell lymphoma

Carcinogenesis (New York), 2007-08, Vol.28 (8), p.1740-1744

2007

Volltextzugriff (PDF)

Propofol weakens hypoxia-aroused apoptosis and autophagy via elevating microRNA-137 in neurocytes

Experimental and molecular pathology, 2020-02, Vol.112, p.104327-104327

2020

Volltextzugriff (PDF)

Synthesis and Characterization of Poly(butylene succinate-co-butylene malate): A New Biodegradable Copolyester Bearing Hydroxyl Pendant Groups

Biomacromolecules, 2003-03, Vol.4 (2), p.437-445

2003

Volltextzugriff (PDF)

Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II Study

The oncologist (Dayton, Ohio), 2022-04, Vol.27 (4), p.253-e312

2022

Volltextzugriff (PDF)

1 – 25 von 421

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(385)
Mit Volltextzugriff
(385)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Impact of BMI on the survival outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis

Estimating Boundary Layer Height from LiDAR Data under Complex Atmospheric Conditions Using Machine Learning

Efficient Lidar Signal Denoising Algorithm Using Variational Mode Decomposition Combined with a Whale Optimization Algorithm

Comparative study on left-sided versus right-sided hepatectomy for resectable peri-hilar cholangiocarcinoma: a systematic review and meta-analysis

Prognostic Value of Peripheral Whole Blood Cell Counts Derived Indexes in Gallbladder Carcinoma: A Systematic Review and Meta-Analysis

Real World Experience of Crizotinib in 104 Patients With ALK Rearrangement Non-small-cell Lung Cancer in a Single Chinese Cancer Center

Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy

Current management of chemotherapy-induced neutropenia in adults: key points and new challenges

Sarcopenia Was a Poor Prognostic Predictor for Patients With Advanced Lung Cancer Treated With Immune Checkpoint Inhibitors

An open label, safety study of Asian patients with advanced non-small-cell lung cancer receiving second-line nivolumab monotherapy (CheckMate 870)

A phase I study of KH901, a conditionally replicating granulocyte-macrophage colony-stimulating factor: Armed oncolytic adenovirus for the treatment of head and neck cancers

Rapid and sensitive determination of vinorelbine in human plasma by liquid chromatography–tandem mass spectrometry and its pharmacokinetic application

A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus

Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study

Weekly albumin-bound paclitaxel/cisplatin versus gemcitabine/cisplatin as first-line therapy for patients with advanced non-small-cell lung cancer: A phase II open-label clinical study

The P38α rs3804451 Variant Predicts Chemotherapy Response and Survival of Patients with Non–Small Cell Lung Cancer Treated with Platinum-Based Chemotherapy

Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial

Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial

Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial

Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trial

Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial

BCRP gene polymorphisms are associated with susceptibility and survival of diffuse large B-cell lymphoma

Propofol weakens hypoxia-aroused apoptosis and autophagy via elevating microRNA-137 in neurocytes

Synthesis and Characterization of Poly(butylene succinate-co-butylene malate): A New Biodegradable Copolyester Bearing Hydroxyl Pendant Groups

Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II Study

Aktive Filter

Suchergebnisse filtern